cro.directory
← Compare landing

Aldeyra Therapeutics vs ProSciento

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryAldeyra TherapeuticsProSciento
SummaryBiopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.Specialized CRO focused on metabolic diseases (obesity, diabetes, MASLD/MASH, cardiovascular, chronic kidney disease) with two decades of expertise, a nationwide registry of 180,000+ participants, and full-service clinical development capabilities from Phase 1 through Phase 3.
Services
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • US FDA Regulatory Strategy
  • Immunology & Inflammation Services
  • Clinical Trial Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Immunology
  • Rare Disease
  • Ophthalmology
  • Metabolic
  • Cardiovascular
  • Nephrology
Phases
  • Phase II
  • Phase III
  • Phase I
  • Phase II
  • Phase III
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
LocationsData not yet provided.
  • Headquarters, Chula Vista, California, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

Aldeyra Therapeutics alternatives · ProSciento alternatives

Markdown mirror: /compare/aldeyra/prosciento.md